← Eichor
Condition: Alopecia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alopecia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
NA · 2 location(s) · Cooler Heads Care Inc. · NCT05484973Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
Phase 3 · 1 location(s) · EMS · NCT04594018Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
NA · 1 location(s) · Acorn Biolabs Inc. · NCT07107841Intralesional Cyclosporine for Alopecia Areata
EARLY_Phase 1 · 1 location(s) · University of California, Davis · NCT07029204Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Phase 3 · 10 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07144345The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Lichen Planopilaris in Routine Clinical
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06512753Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
Phase 3 · 18 location(s) · Sun Pharma Japan Limited · NCT07617597A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Phase 1 · 6 location(s) · Forte Biosciences, Inc. · NCT07205159Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults
NA · 1 location(s) · Ancient + Brave · NCT06603194Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
NA · 1 location(s) · Fujian Medical University Union Hospital · NCT07373054Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · 64 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07133308HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Phase 1 · 2 location(s) · HCW Biologics · NCT07049328Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areat
NA · 1 location(s) · Universidad Autonoma de Nuevo Leon · NCT06564805Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase 4 · 1 location(s) · Wake Forest University Health Sciences · NCT04207931Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07487948Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
NA · 1 location(s) · Montefiore Medical Center · NCT05213936Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers A
Phase 1 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07554222Regeneron AA Multicenter (Dupilumab)
Phase 2 · 3 location(s) · Emma Guttman · NCT05551793Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia
NA · 1 location(s) · Kasr El Aini Hospital · NCT07502976Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
Phase 2 · 2 location(s) · NEXTGEN Bioscience · NCT06104839Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers
NA · 2 location(s) · Industrial Farmacéutica Cantabria, S.A. · NCT06841458CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT05745389Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
NA · 1 location(s) · Jessa Hospital · NCT05177289PALLAS Laser for Skin Diseases
NA · 1 location(s) · Szeged University · NCT07250997Scalp Cooling in MBC
Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT04986579A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · 41 location(s) · Pfizer · NCT07029828Thulium Laser and Growth Factors for Androgenetic Alopecia
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT07079657
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.